586 Topical Nitric Oxide Releasing Therapy With 2% SB414 Cream Downregulated Major Gene Expressions in Patients With Atopic Dermatitis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.662
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ruxolitinib Cream Suppresses Th2 Inflammation in Adult Patients With Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Influence of Silk Clothing Therapy in Patients With Atopic Dermatitis

Dermatology Reports
Dermatology
2019English

Topical Steroid Therapy in Atopic Dermatitis in Theory and Practice

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2015English

PAC‐14028 Cream for Atopic Dermatitis

British Journal of Dermatology
DermatologyMedicine
2019English

Management of Patients With Atopic Dermatitis: The Role of Emollient Therapy

Dermatology Research and Practice
Dermatology
2012English

998 Ruxolitinib Cream Significantly Modulates Inflammatory Profiles of Atopic Dermatitis Patients

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Atopic Phenotype Associations With Rs7927894 Inter Gene Polymorphism on Chromosome 11q13.5 in Czech Adult Patients With Atopic Dermatitis

Global Dermatology
2015English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Gamaglobulin Infusion in Patients With Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy